PMHNP ANCC CERTIFICATION EXAM WITH
VERIFIED QUESTIONS AND ANSWERS||
ALREADY GRADED +|| LATEST VERSION 2026
Domain I: Scientific Foundation
1. Which dopamine pathway is most directly associated with the positive
symptoms of schizophrenia?
A. Nigrostriatal
B. Mesolimbic
C. Tuberoinfundibular
D. Mesocortical
Answer: B. Hyperactivity of the mesolimbic dopamine pathway underlies
positive psychotic symptoms; D2 blockade here reduces hallucinations and
delusions.
2. Why do SSRIs typically take 2–6 weeks to produce clinical
antidepressant benefit despite blocking serotonin reuptake within hours?
A. Hepatic enzyme induction
B. Downstream neuroadaptive changes including receptor downregulation and
increased neuroplasticity
C. Slow accumulation to toxic levels
D. Delayed absorption
Answer: B. Therapeutic benefit lags receptor occupancy because of gradual
neuroadaptation: presynaptic autoreceptor desensitization, postsynaptic receptor
changes, and increased BDNF-mediated neuroplasticity.
3. Benzodiazepines exert their anxiolytic effects primarily by modulating
which neurotransmitter system?
A. Increasing glutamate at NMDA receptors
B. Positively modulating GABA-A receptors, enhancing chloride influx
C. Blocking dopamine D2 receptors
D. Inhibiting acetylcholinesterase
,Answer: B. Benzodiazepines are positive allosteric modulators of the GABA-A
receptor, increasing the frequency of chloride channel opening and producing
CNS inhibition.
4. At low doses, venlafaxine acts primarily on serotonin; at higher doses it
also increases norepinephrine. This medication is best classified as which of
the following?
A. SSRI
B. SNRI
C. MAOI
D. NDRI
Answer: B. Venlafaxine is an SNRI; its noradrenergic effects become clinically
significant at higher doses.
5. Which CYP450 enzyme is primarily responsible for the metabolism of
clozapine?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C19
Answer: A. Clozapine is primarily metabolized by CYP1A2; smoking induces
this enzyme and can lower clozapine levels.
6. A patient on lithium presents with coarse tremor, ataxia, and confusion.
What is the most critical next step?
A. Increase lithium dose
B. Check lithium level stat
C. Add valproate
D. Start risperidone
Answer: B. Symptoms suggest lithium toxicity; immediate level check is
needed. Increasing the dose worsens toxicity.
7. Which brain lobe is primarily associated with executive function,
impulse control, and personality?
A. Temporal lobe
B. Parietal lobe
C. Frontal lobe
D. Occipital lobe
Answer: C. The frontal lobe, particularly the prefrontal cortex, mediates
executive function, impulse control, and personality.
,8. In the dopamine hypothesis of schizophrenia, which statement is TRUE?
A. Positive symptoms result from hypodopaminergic activity in the mesolimbic
pathway
B. Negative symptoms may relate to hypodopaminergic activity in the
mesocortical pathway
C. Both positive and negative symptoms result from excess dopamine in all
pathways
D. Dopamine has no role in schizophrenia
Answer: B. Positive symptoms are linked to mesolimbic hyperactivity; negative
symptoms and cognitive deficits may relate to mesocortical hypodopaminergic
activity.
9. What is the significance of an experimental p-value of 0.05?
A. There is a 5% chance the results are due to chance
B. There is a 95% chance the results are due to chance
C. The results are clinically significant
D. The sample size is adequate
Answer: A. A p-value of 0.05 indicates a 5% probability that the observed
results occurred by chance alone.
10. Which neurotransmitter is most implicated in the pathophysiology of
anxiety disorders?
A. Dopamine
B. GABA
C. Acetylcholine
D. Histamine
Answer: B. GABA is the primary inhibitory neurotransmitter; reduced GABA
activity is associated with anxiety disorders.
11. A patient with treatment-resistant depression has failed two SSRI trials.
The PMHNP considers venlafaxine (Effexor XR). Which statement about
venlafaxine is accurate?
A. It has no noradrenergic effects at any dose
B. It is a pure SSRI
C. It has noradrenergic effects at higher doses
D. It is an MAOI
Answer: C. Venlafaxine is an SNRI; noradrenergic effects become clinically
significant at higher doses.
12. Which receptor subtype is most associated with the antidepressant
effects of atypical antipsychotics when used adjunctively?
A. D2
, B. 5-HT2A
C. H1
D. M1
Answer: B. 5-HT2A antagonism contributes to antidepressant augmentation
effects of atypical antipsychotics such as aripiprazole and quetiapine.
13. What is the primary mechanism of action of bupropion?
A. Serotonin reuptake inhibition
B. Norepinephrine-dopamine reuptake inhibition
C. GABA-A receptor potentiation
D. Monoamine oxidase inhibition
Answer: B. Bupropion is an NDRI; it inhibits reuptake of norepinephrine and
dopamine.
14. Which of the following is a positive allosteric modulator at GABA-A
receptors?
A. Flumazenil
B. Lorazepam
C. Naltrexone
D. Varenicline
Answer: B. Lorazepam is a benzodiazepine that positively modulates GABA-A
receptors.
15. A patient on clozapine reports fever, sore throat, and lethargy. What is
the priority action?
A. Increase the clozapine dose
B. Obtain a CBC immediately
C. Add an antibiotic
D. Switch to olanzapine
Answer: B. These symptoms suggest possible agranulocytosis; immediate CBC
is required.
16. Which of the following is true about the tuberoinfundibular dopamine
pathway?
A. It regulates movement
B. It regulates prolactin secretion
C. It regulates mood
D. It regulates appetite
Answer: B. Blockade of tuberoinfundibular dopamine receptors can lead to
hyperprolactinemia.
VERIFIED QUESTIONS AND ANSWERS||
ALREADY GRADED +|| LATEST VERSION 2026
Domain I: Scientific Foundation
1. Which dopamine pathway is most directly associated with the positive
symptoms of schizophrenia?
A. Nigrostriatal
B. Mesolimbic
C. Tuberoinfundibular
D. Mesocortical
Answer: B. Hyperactivity of the mesolimbic dopamine pathway underlies
positive psychotic symptoms; D2 blockade here reduces hallucinations and
delusions.
2. Why do SSRIs typically take 2–6 weeks to produce clinical
antidepressant benefit despite blocking serotonin reuptake within hours?
A. Hepatic enzyme induction
B. Downstream neuroadaptive changes including receptor downregulation and
increased neuroplasticity
C. Slow accumulation to toxic levels
D. Delayed absorption
Answer: B. Therapeutic benefit lags receptor occupancy because of gradual
neuroadaptation: presynaptic autoreceptor desensitization, postsynaptic receptor
changes, and increased BDNF-mediated neuroplasticity.
3. Benzodiazepines exert their anxiolytic effects primarily by modulating
which neurotransmitter system?
A. Increasing glutamate at NMDA receptors
B. Positively modulating GABA-A receptors, enhancing chloride influx
C. Blocking dopamine D2 receptors
D. Inhibiting acetylcholinesterase
,Answer: B. Benzodiazepines are positive allosteric modulators of the GABA-A
receptor, increasing the frequency of chloride channel opening and producing
CNS inhibition.
4. At low doses, venlafaxine acts primarily on serotonin; at higher doses it
also increases norepinephrine. This medication is best classified as which of
the following?
A. SSRI
B. SNRI
C. MAOI
D. NDRI
Answer: B. Venlafaxine is an SNRI; its noradrenergic effects become clinically
significant at higher doses.
5. Which CYP450 enzyme is primarily responsible for the metabolism of
clozapine?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C19
Answer: A. Clozapine is primarily metabolized by CYP1A2; smoking induces
this enzyme and can lower clozapine levels.
6. A patient on lithium presents with coarse tremor, ataxia, and confusion.
What is the most critical next step?
A. Increase lithium dose
B. Check lithium level stat
C. Add valproate
D. Start risperidone
Answer: B. Symptoms suggest lithium toxicity; immediate level check is
needed. Increasing the dose worsens toxicity.
7. Which brain lobe is primarily associated with executive function,
impulse control, and personality?
A. Temporal lobe
B. Parietal lobe
C. Frontal lobe
D. Occipital lobe
Answer: C. The frontal lobe, particularly the prefrontal cortex, mediates
executive function, impulse control, and personality.
,8. In the dopamine hypothesis of schizophrenia, which statement is TRUE?
A. Positive symptoms result from hypodopaminergic activity in the mesolimbic
pathway
B. Negative symptoms may relate to hypodopaminergic activity in the
mesocortical pathway
C. Both positive and negative symptoms result from excess dopamine in all
pathways
D. Dopamine has no role in schizophrenia
Answer: B. Positive symptoms are linked to mesolimbic hyperactivity; negative
symptoms and cognitive deficits may relate to mesocortical hypodopaminergic
activity.
9. What is the significance of an experimental p-value of 0.05?
A. There is a 5% chance the results are due to chance
B. There is a 95% chance the results are due to chance
C. The results are clinically significant
D. The sample size is adequate
Answer: A. A p-value of 0.05 indicates a 5% probability that the observed
results occurred by chance alone.
10. Which neurotransmitter is most implicated in the pathophysiology of
anxiety disorders?
A. Dopamine
B. GABA
C. Acetylcholine
D. Histamine
Answer: B. GABA is the primary inhibitory neurotransmitter; reduced GABA
activity is associated with anxiety disorders.
11. A patient with treatment-resistant depression has failed two SSRI trials.
The PMHNP considers venlafaxine (Effexor XR). Which statement about
venlafaxine is accurate?
A. It has no noradrenergic effects at any dose
B. It is a pure SSRI
C. It has noradrenergic effects at higher doses
D. It is an MAOI
Answer: C. Venlafaxine is an SNRI; noradrenergic effects become clinically
significant at higher doses.
12. Which receptor subtype is most associated with the antidepressant
effects of atypical antipsychotics when used adjunctively?
A. D2
, B. 5-HT2A
C. H1
D. M1
Answer: B. 5-HT2A antagonism contributes to antidepressant augmentation
effects of atypical antipsychotics such as aripiprazole and quetiapine.
13. What is the primary mechanism of action of bupropion?
A. Serotonin reuptake inhibition
B. Norepinephrine-dopamine reuptake inhibition
C. GABA-A receptor potentiation
D. Monoamine oxidase inhibition
Answer: B. Bupropion is an NDRI; it inhibits reuptake of norepinephrine and
dopamine.
14. Which of the following is a positive allosteric modulator at GABA-A
receptors?
A. Flumazenil
B. Lorazepam
C. Naltrexone
D. Varenicline
Answer: B. Lorazepam is a benzodiazepine that positively modulates GABA-A
receptors.
15. A patient on clozapine reports fever, sore throat, and lethargy. What is
the priority action?
A. Increase the clozapine dose
B. Obtain a CBC immediately
C. Add an antibiotic
D. Switch to olanzapine
Answer: B. These symptoms suggest possible agranulocytosis; immediate CBC
is required.
16. Which of the following is true about the tuberoinfundibular dopamine
pathway?
A. It regulates movement
B. It regulates prolactin secretion
C. It regulates mood
D. It regulates appetite
Answer: B. Blockade of tuberoinfundibular dopamine receptors can lead to
hyperprolactinemia.
